经鼻高流量氧疗患者肠内喂养的安全性
本研究为单中心回顾性队列,纳入2020年1月1日至2022年12月31日期间接受HFNC的成人住院患者220例,排除慢性全肠外营养、慢性气管造口、全喉切除术史及「不插管」医嘱状态者。主要终点为呼吸衰竭进展(HFNC升级至无创正压通气、机械通气或体外膜肺氧合)。进展者57例,其中肠内喂养19例(33.3%),禁食38例(66.7%)。多因素混合效应线性回归显示肠内喂养者呼吸衰竭进展风险更低(OR 0.33;95%CI 0.18-0.58;p<0.001),倾向性评分匹配分析结果一致(OR 0.30;95%CI 0.15-0.58;p<0.001)。作者认为肠内营养与较低呼吸衰竭进展风险相关,且不增加不良临床结局风险,需前瞻性多中心研究证实。
要点
- HFNC成人患者肠内喂养与呼吸衰竭进展风险降低相关:OR 0.33(95%CI 0.18-0.58;p<0.001)。
- 倾向性评分匹配分析结果一致:肠内喂养者呼吸衰竭进展OR 0.30(95%CI 0.15-0.58;p<0.001)。
- 呼吸衰竭进展者57例中,肠内喂养19例(33.3%),禁食38例(66.7%)。
- 肠内喂养未增加不良临床结局风险。
- 作者认为需前瞻性多中心研究证实这些发现。
适用人群与场景
- 纳入:2020年1月1日至2022年12月31日期间在Keck Hospital of the University of Southern California(三级学术医院)接受HFNC治疗的成人住院患者。
- 排除:慢性全肠外营养、慢性气管造口、全喉切除术史、「不插管」医嘱状态。
研究设计与关键结果
- 研究类型:单中心回顾性队列研究;样本量220例;中位年龄62.6岁,男性54.1%,白人43.6%。
- 主要终点:呼吸衰竭进展(HFNC升级至无创正压通气、机械通气或体外膜肺氧合) occurred in 57例,其中肠内喂养19例(33.3%),禁食38例(66.7%)。
- 多因素混合效应线性回归:肠内喂养者呼吸衰竭进展风险更低(OR 0.33;95%CI 0.18-0.58;p<0.001)。
- 倾向性评分匹配分析:肠内喂养者呼吸衰竭进展风险更低(OR 0.30;95%CI 0.15-0.58;p<0.001)。
- 肠内喂养未增加不良临床结局风险。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,HFNC患者肠内营养与较低呼吸衰竭进展风险相关,且不增加不良临床结局风险。
- 作者认为需前瞻性多中心研究证实这些发现。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The goal of this study was to assess the effect of enteral feeding on aspiration risk and progression of respiratory failure in adults on high-flow nasal cannula (HFNC) oxygen therapy.
DESIGN: Single-center retrospective cohort study.
SETTING: Keck Hospital of the University of Southern California, a tertiary care academic hospital.
PATIENTS: Hospitalized adults treated with HFNC between January 1, 2020, and December 31, 2022, were included. Exclusion criteria were chronic total parenteral nutrition, chronic tracheostomy, history of total laryngectomy, and "Do Not Intubate" code status.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The primary outcome was the progression of respiratory failure from HFNC to noninvasive positive pressure ventilation, mechanical ventilation, or extracorporeal membrane oxygenation. We included 220 patients in the primary analysis. The median age was 62.6 years, 54.1% of patients were male, and 43.6% of patients were White. The primary outcome of progression of respiratory failure occurred in 57 patients, of whom 19 (33.3%) were feeding enterally and 38 (66.7%) were NPO at the time of progression. Patients feeding enterally were less likely than those who were NPO to have progression of respiratory failure in a multivariate mixed effects linear regression model (odds ratio [OR], 0.33; 95% CI, 0.18-0.58; p < 0.001). Patients feeding enterally remained less likely to have progression of respiratory failure in a propensity score-matched analysis (OR, 0.30; 95% CI, 0.15-0.58; p < 0.001).
CONCLUSIONS: In this single-center, retrospective cohort, enteral nutrition in patients on HFNC was associated with lower risk of progression of respiratory failure and was not associated with increased risk of poor clinical outcomes. Prospective multicenter studies are needed to confirm these findings.
参考来源
- West MR, Chen EJ, Rodman J, et al. Safety of Enteral Feeding in Patients on High-Flow Nasal Cannula. Crit Care Med. 2026. PMID: 41705878. doi:10.1097/CCM.0000000000007074
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。